Search

Your search keyword '"Elephantiasis, Filarial transmission"' showing total 399 results

Search Constraints

Start Over You searched for: Descriptor "Elephantiasis, Filarial transmission" Remove constraint Descriptor: "Elephantiasis, Filarial transmission"
399 results on '"Elephantiasis, Filarial transmission"'

Search Results

101. Prevalence of lymphatic filariasis in a tea garden worker population of Dibrugarh (Assam), India after six rounds of mass drug administration.

102. Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration.

103. Comparison of Methods for Xenomonitoring in Vectors of Lymphatic Filariasis in Northeastern Tanzania.

104. Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana.

105. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.

106. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.

107. Modelling strategies to break transmission of lymphatic filariasis--aggregation, adherence and vector competence greatly alter elimination.

108. Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana.

109. The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration.

110. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].

111. Climate Change and Spatiotemporal Distributions of Vector-Borne Diseases in Nepal--A Systematic Synthesis of Literature.

112. Impregnating hessian strips with the volatile pyrethroid transfluthrin prevents outdoor exposure to vectors of malaria and lymphatic filariasis in urban Dar es Salaam, Tanzania.

113. Evaluation of traps and lures for mosquito vectors and xenomonitoring of Wuchereria bancrofti infection in a high prevalence Samoan Village.

114. Toxicity of some plant extracts against vector of lymphatic filariasis, Culex pipiens.

115. Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?

116. Sibling species of the Anopheles funestus group, and their infection with malaria and lymphatic filarial parasites, in archived and newly collected specimens from northeastern Tanzania.

117. Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directions.

118. Factors associated with the performance and cost-effectiveness of using lymphatic filariasis transmission assessment surveys for monitoring soil-transmitted helminths: a case study in Kenya.

119. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.

120. Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.

121. How effective is integrated vector management against malaria and lymphatic filariasis where the diseases are transmitted by the same vector?

122. Molecular epidemiology, phylogeny and evolution of the filarial nematode Wuchereria bancrofti.

123. Non-endemic cases of lymphatic filariasis.

124. Functional response analysis of Anisops sardea (Hemiptera: Notonectidae) against Culex quinquefasciatus in laboratory condition.

125. Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa.

126. Spatio-temporal distribution of dengue and lymphatic filariasis vectors along an altitudinal transect in Central Nepal.

127. Impact of MDA and the prospects of elimination of the lone focus of diurnally sub periodic lymphatic filariasis in Nicobar Islands, India.

128. Integrated school-based surveillance for soil-transmitted helminth infections and lymphatic filariasis in Gampaha district, Sri Lanka.

129. The epidemiology of lymphatic filariasis in Ghana, explained by the possible existence of two strains of Wuchereria bancrofti.

130. No evidence for lymphatic filariasis transmission in big cities affected by conflict related rural-urban migration in Sierra Leone and Liberia.

131. Seventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision by scaling up, scaling down, and reaching out.

132. Invited editorial: zoonotic lymphatic filariasis in the Americas: trends in epidemiology, diagnosis and treatment, with special emphasis on brugian filariasis.

133. Survival of diurnally sub periodic Wuchereria bancrofti in Downsiomyia nivea (Diptera: Culicidae): a density dependent factor from Andaman & Nicobar Islands.

134. Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation.

135. Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.

136. Long-lasting insecticidal nets are synergistic with mass drug administration for interruption of lymphatic filariasis transmission in Nigeria.

137. Lymphatic filariasis in Luangwa District, South-East Zambia.

138. Population studies of the filarial vector Aedes polynesiensis (Diptera: Culicidae) in two island settings of French Polynesia.

139. Lymphatic filariasis transmission risk map of India, based on a geo-environmental risk model.

140. Wuchereria bancrofti transmission pattern in southern Mali prior to and following the institution of mass drug administration.

141. Insecticidal bed nets and filariasis transmission in Papua New Guinea.

142. Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission.

143. Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.

144. Surveillance of lymphatic filariasis after stopping ten years of mass drug administration in rural communities in south India.

145. Evaluation of PCR-ELISA as a tool for monitoring transmission of Wuchereria bancrofti in District of Gampaha, Sri Lanka.

146. Survey of Bancroftian filariasis infection in humans and Culex mosquitoes in the western Brazilian Amazon region: implications for transmission and control.

147. Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity?

148. Malaria and lymphatic filariasis: the case for integrated vector management.

149. Population migration: implications for lymphatic filariasis elimination programmes.

150. Urban lymphatic filariasis.

Catalog

Books, media, physical & digital resources